| Application no. and date | 14793565.4 (espacenet) (Federated) (European Patent Register), 20141105 | | Patent/reg. no. and date | DK/EP 3066097, 20170816 | | Publication date | 20160914 | | Priority no. and date | EP 13192177, 20131108 | | EP pub. no. and date |
EP 3066097 20160914 | | Effective date | | | Applicant/owner | Bayer Pharma Aktiengesellschaft, Müllerstrasse 178
13353 Berlin, DE | | Applicant ref. no. | BBS BHC131069-PCT-EP | | Inventor | JESKE, Mario, Schneebacher Weg 20
42699 Solingen, DE,
KEIL, Birgit, Sudetenstrasse 36
40231 Düsseldorf, DE,
FÜRSTNER, Chantal, Arnoldstrasse 33
45478 Mülheim/Ruhr, DE,
OLENIK, Britta, Birkenstrasse 30
46242 Bottrop, DE,
HINZ, Martin-Holger, Mörikeweg 15
42499 Hückeswagen, DE,
Ackerstaff, Jens, Christophstrasse 27
40225 Düsseldorf, DE | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/513 (2006.01) , A61P 9/00 (2006.01) , C07D 413/04 (2006.01) | | Title | SALTE AF 1-(3-METHYL-2-OXO-2,3-DIHYDRO-1,3-BENZOXAZOL-6-YL)-2,4-DIOXO-3-[(1R)-4-(TRIFLUORMETHYL)-2,3-DIHYDRO-1H-INDEN-1-YL]-1,2,3,4-TETRAHYDROPYRIMIDIN-5-CARBOXYLSYRE | | Int. application no. | EP2014073801 | | Int. publication no. | WO2015067652 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
